$205 Million is the total value of Foresite Capital Management IV, LLC's 12 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 350.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KROS | New | Keros Therapeutics, Inc. | $53,567,000 | – | 1,428,071 | +100.0% | 26.09% | – |
| KURA | Buy | Kura Oncology, Inc. | $21,320,000 | +2204.9% | 1,307,982 | +1306.4% | 10.39% | +811.1% |
| FULC | Buy | Fulcrum Therapeutics, Inc. | $20,740,000 | +73.9% | 1,133,948 | +13.5% | 10.10% | -31.3% |
| PCVX | New | Vaxcyte, Inc. | $19,624,000 | – | 620,821 | +100.0% | 9.56% | – |
| GBIO | New | Generation Bio Co. | $18,017,000 | – | 857,942 | +100.0% | 8.78% | – |
| CBAY | New | Cymabay Therapeutics, Inc. | $9,925,000 | – | 2,843,893 | +100.0% | 4.84% | – |
| ORIC | New | Oric Pharmaceuticals, Inc. | $4,216,000 | – | 125,000 | +100.0% | 2.05% | – |
| DRNA | New | Dicerna Pharmaceuticals, Inc. | $635,000 | – | 25,000 | +100.0% | 0.31% | – |
| RTRX | New | Retrophin, Inc. | $612,000 | – | 30,000 | +100.0% | 0.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 23 | Q3 2023 | 14.8% |
| Kura Oncology, Inc. | 19 | Q2 2024 | 25.6% |
| Aclaris Therapeutics, Inc. | 18 | Q3 2023 | 18.9% |
| Kinnate Biopharma Inc. | 14 | Q1 2024 | 41.8% |
| Pharvaris N.V. | 14 | Q2 2024 | 57.3% |
| Lyell Immunopharma, Inc. | 13 | Q2 2024 | 29.2% |
| Myokardia, Inc. | 12 | Q3 2020 | 17.8% |
| Cytokinetics Incorporated | 11 | Q2 2021 | 31.6% |
| Insmed Incorporated | 10 | Q1 2020 | 19.2% |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | Q1 2020 | 14.5% |
View Foresite Capital Management IV, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-14 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-04-05 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 4 | 2023-05-10 |
| 4 | 2023-02-22 |
View Foresite Capital Management IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.